Hikma Pharmaceuticals shares slump as lowers mid-term outlook
(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reduced medium term guidance and cut the top-end of its 2025 core operating profit view amid a delayed start to production at a US site. Read More